List details
Basic info
Status | Opinion Adopted |
---|---|
Submitter | Germany |
Regulatory programme |
|
ATP number and date | ATP07 - (25/07/2015), 01/01/2017 |
Link to ATP |
|
Classification
Harmonised classification at the time of the proposal |
|
---|---|
Proposed harmonised classification by the dossier submitter |
|
Specific concentration limits at the time of the proposal | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,25 % ≤ C < 1 % Skin Irrit. 2; C ≥ 1 % Eye Irrit. 2; C ≥ 1 % |
Intention timeline
Date of intention | 2012-01-05 |
---|---|
Submitted for accordance check | 2012-01-05 |
Final submission date | 2013-04-25 |
Start of consultation | 2013-06-06 |
Deadline for commenting | 2013-07-22 |
Date of opinion | 2013-12-05 |
Legal deadline for opinion adoption | 2014-12-05 |
Documents
CLH report |
|
---|---|
Comments received |
|
RAC opinion |
|
Background document |
|
Related substances
No substances related to this record were found in our database.
Related regulatory records
- There are no related (i.e. sharing the same name or identifier) regulatory records in our database
Record history
The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.
This version
July 13, 2022
- Name: 4-(tributylstannyl)-1,3-thiazole → 2-(Tributylstannyl)pyridine
- CAS: 173979-01-6 → 17997-47-6
- EC: 677-930-4 → 628-762-5
June 6, 2022
- Name: 2-(Tributylstannyl)pyridine → 4-(tributylstannyl)-1,3-thiazole
- CAS: 17997-47-6 → 173979-01-6
- EC: 628-762-5 → 677-930-4